Greg Cook is the senior director of access, policy and advocacy at Bristol Myers Squibb Australia. In a Q&A with BioPharmaDispathch, he discusses the 'access' challenge and the need for the health technology assessment review to focus on achieving the 'North Star' for patients. …
Faster patient access must be the 'North Star' for HTA review
March 22, 2023 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
Georgia Forrest
New Stories
-
Telix files for European approval of brain cancer imaging candidate TLX101-Px
February 18, 2026 - - Australian Biotech -
IDT signals turnaround as revenue rises and losses narrow under strategic reset
February 18, 2026 - - Latest News -
Nyrada advances lead candidate into mid-stage trial as momentum builds across programs
February 18, 2026 - - Australian Biotech -
Novo Nordisk backs community-led initiative that aims to transform life for Logan’s children
February 18, 2026 - - Latest News -
CSL and Lilly strike strategic deal to advance promising anti-inflammatory therapy
February 18, 2026 - - Latest News -
Targeted blood cancer treatments proposed for funding in New Zealand
February 18, 2026 - - Latest News -
Percheron targets next wave of immunotherapy with novel VISTA checkpoint candidate
February 18, 2026 - - Australian Biotech